References
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 2000
- Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001;285(1):60–66
- Surgeon General of the United States. Mental Health: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 1999. http://mentalhealth.sarnhsa.gov/features/surgeongeneralreport/home.asp. Accessed August 9, 2010
- Centers for Disease Control and Prevention (CDC). Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder—United States, 2003. MMWR Morb Mortal Wkly Report. 2005;54(34):842–847
- Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857–864
- Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):724–732
- Institute of Medicine. Clinical Practice Guidelines: Directions for a New Program. Field MJ, Lohr KN, eds. Committee to Advise the Public Health Service on Clinical Practice Guidelines, Institute of Medicine. Washington, DC: National Academy Press; 1990
- AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12(1):18–23
- American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033–1044
- American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics. 2000;105(5):1158–1170
- Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921
- National Institute for Health and Clinical Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People, and Adults. London, UK: National Collaborating Centre for Mental Health; 2008. http://www.nice.org.uk/nicemedia/pdf/ADHDFullGuideline.pdf. Accessed August 9, 2010
- Scottish Intercollegiate Guidelines Network. Management of attention deficit and hyperkinetic disorders in children and young people. A National Clinical Guideline NHS Quality Improvement Scotland (NHS QIS) 2009. http://www.sign.ac.uk/pdf/sign112.pdf. Accessed August 9, 2010
- The Royal Austalasian College of Physicians. Australian Guidelines on Attention Deficit Hyperactivity Disorder (ADHD). 2009. http://www.nhmrc.gov.au/publications/synopses/adhd_draft.htm. Accessed August 5, 2010
- Nutt DJ, Fone K, Asherson P, ; Association for Psychopharmacology. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007;21(1):10–41
- Taylor E, Döpfner M, Sergeant J, . European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry. 2004;13( suppl 1):17–30
- Pliska SR, Crismon ML, Hughes CW, ; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642–657
- Pliszka SR, Lopez M, Crismon ML. A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42(3):279–287
- Magellan Health Services, Clinical Practice Guideline Task Force, Clinical Practice Guideline for Patients with Attention Deficit/Hyperactivity Disorder, 2005–2010. Magellan Health Services, Inc. http://www.westernhealth.com/providers/downloads/Clinical_Practice_Guidline_ADHD.pdf. Accessed August 9, 2010
- American Academy of Child and Adolescent Psychiatry (Pliszka SR, Bukstein OG). Attention Deficit/Hyperactivity Disorder, Version 3.0. Baltimore, MD: International Guidelines Center
- Davis K, Schoenbaum SC, Audet AM. A 2020 vision of patient-centered primary care. J Gen Intern Med. 2005;20(10):953–957